Skip to content

Personal protein digestion variability

Personal protein digestion variability - Personal protein digestion variability

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51132
Enrollment
18
Registered
2021-07-29
Start date
2021-10-26
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

opname van eiwitten protein digestion

Interventions

Research subjects will receive two times an easy digestible protein source wey and three times a poorly digestible protein source lucerne. Both representing a 20g protein load.

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: * Apparently healthy men and women; * Age between 18 and 40 years; * Body mass index (BMI) between 18.5 and 30 kg/m2 ; * Having veins suitable for blood sampling via a catheter (judged by study nurse/ medical doctor).

Exclusion criteria

Exclusion criteria: * Any metabolic, gastrointestinal, inflammatory or chronic disease (such as diabetes, anaemia, hepatitis, cardiovascular disease),or having a condition or disease that may lead to an impaired immune system * History of gastrointestinal surgery or having (serious) gastrointestinal complaints; * History of liver dysfunction (cirrhosis, hepatitis) or liver surgery; * Kidney dysfunction (self-reported); * Any use of medication that may suppress the immune system, this will be judged by the medical supervisor; * Use of medication that may influence the study results, such as gastric acid inhibitors, laxatives, stomach protectors and drugs that can affect intestinal motility, this will be judged by the medical supervisor; * Anaemia (Hb values

Design outcomes

Primary

MeasureTime frame
The main study parameter is AA uptake kinetics e.g. the appearance of free amino acids in blood samples collected before and after consumption. We will determine and quantify between, and within-subject variability.

Secondary

MeasureTime frame
GI complaints via questionnaire

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)